SCHEMBL19625403

SCHEMBL19625403

COc1sc(C(C)(C)C)nc1-c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.38
ALOX5 P09917 2/20 0.38
PTGS2 P35354 1/20 0.37
KDM4E B2RXH2 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
F2RL3 Q96RI0 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
XBP1 P17861 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GCGR P47871 1/20 0.35
DHODH Q02127 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19627014 0.80 ALDH1A1 (0.51) PTGDR2ALOX5PTGS2KDM4EL3MBTL1
SCHEMBL19625298 0.79 APEX1 (0.47) PTGDR2PTGS2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL19625359 0.78 PTGS2 (0.45) PTGDR2PTGS2KDM4EL3MBTL1HTT
SCHEMBL19625357 0.75 HTT (0.49) PTGDR2PTGS2KDM4EALDH1A1HTT
SCHEMBL19627032 0.75 CYP1A2 (0.40) PTGDR2ALOX5KDM4EL3MBTL1F2RL3
SCHEMBL19625456 0.75 PTGS2 (0.40) PTGDR2PTGS2KDM4EL3MBTL1ALDH1A1
SCHEMBL5525665 0.73 RAB9A (0.51) PTGDR2PTGS2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL19625496 0.73 HTT (0.65) PTGDR2KDM4ESMN1; SMN2ALDH1A1HTT
SCHEMBL21721492 0.72
SCHEMBL19625418 0.72 ALDH1A1 (0.43) PTGDR2PTGS2KDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 PTGDR2 443/4885ALOX5 1995/4885PTGS2 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.